Article
type: Class

Document
type: Class

Anualidad
type: Class

Information Content Entity
type: Class

Continuant
type: Class

Entity
type: Class

Congress communication
type: Class

Generically Dependent Continuant
type: Class

Conference Paper
type: Class

2003
type: Class

individual
type: Document
rights: termsOfUse
date: 2026-08-14T20:43:12
publisher: Peliminary results of phase i-ii study of the combination of oxaliplatin, irinotecan and 5-fu in patients with advanced solid (phase i) and colorectal (phase ii) tumors.
label: RDF description of Peliminary results of phase i-ii study of the combination of oxaliplatin, irinotecan and 5-fu in patients with advanced solid (phase i) and colorectal (phase ii) tumors. - http://research.umh.es/vivo/pub/comunicacion/22050

Peliminary results of phase i-ii study of the combination of oxaliplatin, irinotecan and 5-fu in patients with advanced solid (phase i) and colorectal (phase ii) tumors.
type: Anualidad
type: Information Content Entity
type: 2003
related by: AutorExt:38135_2003-Comunicación:22050
ARG_2000028: 22050 vcard
related by: AutorExt:38134_2003-Comunicación:22050
type: Continuant
type: Conference Paper
type: Entity
type: Thing
related by: AutorExt:38138_2003-Comunicación:22050
related by: Autor:5522-Comunicación:22050
most specific type: Conference Paper
most specific type: 2003
date time value: 22050 pubdate
related by: AutorExt:38137_2003-Comunicación:22050
most specific type: Congress communication
related by: AutorExt:38133_2003-Comunicación:22050
type: Congress communication
related by: AutorExt:38141_2003-Comunicación:22050
related by: AutorExt:38136_2003-Comunicación:22050
type: Article
type: Document
type: Generically Dependent Continuant
related by: AutorExt:38140_2003-Comunicación:22050
related by: AutorExt:38139_2003-Comunicación:22050
RO_0002353: American Society of Clinical Oncology 39th Annual Meeting

AutorExt:38135_2003-Comunicación:22050
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Peliminary results of phase i-ii study of the combination of oxaliplatin, irinotecan and 5-fu in patients with advanced solid (phase i) and colorectal (phase ii) tumors.

AutorExt:38134_2003-Comunicación:22050
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Peliminary results of phase i-ii study of the combination of oxaliplatin, irinotecan and 5-fu in patients with advanced solid (phase i) and colorectal (phase ii) tumors.

AutorExt:38138_2003-Comunicación:22050
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Peliminary results of phase i-ii study of the combination of oxaliplatin, irinotecan and 5-fu in patients with advanced solid (phase i) and colorectal (phase ii) tumors.

Autor:5522-Comunicación:22050
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Peliminary results of phase i-ii study of the combination of oxaliplatin, irinotecan and 5-fu in patients with advanced solid (phase i) and colorectal (phase ii) tumors.

AutorExt:38137_2003-Comunicación:22050
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Peliminary results of phase i-ii study of the combination of oxaliplatin, irinotecan and 5-fu in patients with advanced solid (phase i) and colorectal (phase ii) tumors.

AutorExt:38133_2003-Comunicación:22050
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Peliminary results of phase i-ii study of the combination of oxaliplatin, irinotecan and 5-fu in patients with advanced solid (phase i) and colorectal (phase ii) tumors.

AutorExt:38141_2003-Comunicación:22050
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Peliminary results of phase i-ii study of the combination of oxaliplatin, irinotecan and 5-fu in patients with advanced solid (phase i) and colorectal (phase ii) tumors.

AutorExt:38136_2003-Comunicación:22050
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Peliminary results of phase i-ii study of the combination of oxaliplatin, irinotecan and 5-fu in patients with advanced solid (phase i) and colorectal (phase ii) tumors.

AutorExt:38140_2003-Comunicación:22050
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Peliminary results of phase i-ii study of the combination of oxaliplatin, irinotecan and 5-fu in patients with advanced solid (phase i) and colorectal (phase ii) tumors.

AutorExt:38139_2003-Comunicación:22050
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Peliminary results of phase i-ii study of the combination of oxaliplatin, irinotecan and 5-fu in patients with advanced solid (phase i) and colorectal (phase ii) tumors.

American Society of Clinical Oncology 39th Annual Meeting
type: Entity
type: Conference
RO_0002234: Peliminary results of phase i-ii study of the combination of oxaliplatin, irinotecan and 5-fu in patients with advanced solid (phase i) and colorectal (phase ii) tumors.
type: Anualidad
type: 2003
type: BFO_0000015
type: Event
type: BFO_0000003
type: Thing